Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Denver, Colorado


Purpose:

The purpose of this clinical research study is to learn if Abatacept or Infliximab in combination with Methotrexate demonstrate a greater reduction in disease activity over placebo.


Criteria:

Inclusion Criteria: - Diagnosis of Rheumatoid Arthritis - At least 3 months prior treatment with Methotrexate (MTX) - At least 10 swollen joints and 12 tender joints and C-Reactive Protein of at least 1 mg/dl - Washout required for other disease modifying anti-rheumatic drugs (DMARDS) Exclusion Criteria: - participants who have failed more than 3 DMARDs - participants previously treated with an approved biologic drug - History of cancer in the last 5 years - Severe or recurrent bacterial infection - Any previous or current medical conditions that are contraindications to the use of TNF blocking agents - Women of Child Bearing Potential


NCT ID:

NCT00095147


Primary Contact:

Study Director
Bristol-Myers Squibb
Bristol-Myers Squibb


Backup Contact:

N/A


Location Contact:

Denver, Colorado
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.